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Detection of the carbapenemase 
gene blaVIM-5 in members of the 
Pseudomonas putida group isolated 
from polluted Nigerian wetlands
Olawale O. Adelowo  1,2, John Vollmers3, Ines Mäusezahl1, Anne-Kristin Kaster3 & 
Jochen A. Müller  1
There are increasing concerns about possible dissemination of clinically relevant antibiotic resistance 
genes, including genes encoding for carbapenemases in the environment. However, little is known 
about environmental distribution of antibiotic resistance in Africa. In this study, four polluted urban 
wetlands in Nigeria were investigated as potential reservoirs of carbapenem-resistant bacteria 
(CRB). CRB were isolated from the wetlands, characterized by Blue-Carba test, MIC determinations 
and whole genome sequencing (WGS). Nine of 65 bacterial isolates identified as members of the 
Pseudomonas putida group (P. plecoglossicida and P. guariconensis, respectively) harboured the 
metallo-beta-lactamase gene blaVIM-5. WGS revealed the blaVIM-5 in three novel Tn402-like class 1 
integron structures containing the cassette arrays aadB|blaVIM-5|blaPSE-1, aadB|blaVIM-5|aadB|blaPSE-1, and 
blaVIM-5|aadB|tnpA|blaPSE-1|smr2|tnpA, respectively. Strains carrying the aadB|blaVIM-5|blaPSE-1 cassette 
also carried an identical integron without blaVIM-5. In addition, the strains harboured another Tn402-like 
class 1 integron carrying bcr2, several multidrug resistance efflux pumps, and at least one of ampC, 
aph(3”)-lb, aph(6)-ld, tetB, tetC, tetG, floR, and macAB. This is the first report of a carbapenemase 
gene in bacteria from environmental sources in Nigeria and the first report of blaVIM-5 in environmental 
bacteria isolates. This result underscores the role of the Nigerian environment as reservoir of bacteria 
carrying clinically relevant antibiotic resistance genes.
Antibiotic resistance is an increasing global problem with significant impact on human health1. This problem 
is aggravated by the emergence of resistance in the natural environment2–5. The increasing global detection of 
carbapenemase genes in bacteria from non-clinical sources6–14 is a disturbing observation that coincides with the 
recognition that natural ecosystems affected by anthropogenic pollution might play a role in the evolution and 
dissemination of clinically important antibiotic resistance2–5. This scenario point to the need for extended sur-
veillance of non-clinical sources as reservoirs of bacteria harbouring genes encoding resistance to carbapenems 
for clinical and public health safety14–16.
Aquatic ecosystems are particularly important as conduits for the dissemination of antibiotic resistant bacteria 
and antibiotic resistance genes into other environmental compartments and eventually the human population17. 
Thus far, very few studies have investigated African aquatic ecosystems as reservoir of bacteria carrying antibiotic 
resistance genes of public health interest18–20 and none that we know of has investigated the presence of carbapene-
mase genes in environmental bacteria isolates in Nigeria, the most populous nation in Africa. Reports of carbapen-
emase genes in bacteria from Nigeria have been limited to clinical bacteria isolates21–25. The aforementioned studies 
reported detection of the carbapenemase genes blaOXA-23, blaOXA-48, blaOXA-181, blaNDM-1, blaGES, blaVIM-1, blaVIM-2 
and blaKPC in clinical bacterial isolates. In addition, Walkty et al.26 reported the isolation of a Pseudomonas aerugi-
nosa, Klebsiella pneumoniae and Escherichia coli carrying blaVIM-2, blaNDM-1 and blaOXA-181 respectively in a patient 
admitted to a Canadian hospital after prolonged hospitalisation in Nigeria. Only recently, Kazmierczak et al.27 
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reported the detection of the carbapenemase gene blaVIM-5 in clinical isolates of Proteus mirabilis and Pseudomonas 
aeruginosa from Nigeria, however, no information was provided about the genetic context of the genes. More 
importantly, very little is known about the genetic platforms linked to detected carbapenemase genes in 
Africa28,29. These are important omissions considering the widespread and uncontrolled use of beta-lactam antibi-
otics in human clinical therapy and food animal production in Nigeria30, and the ubiquitous release of untreated 
wastewater from several point and non-point sources into the aquatic ecosystem as a result of poor sanitation31. 
These predisposing factors for the proliferation of antibiotic resistance in environmental reservoirs make the 
investigation of Nigerian aquatic ecosystem as reservoir of carbapenemase-producing bacteria an urgent task.
The objective of this study was to investigate four polluted urban wetlands in Nigeria as potential reservoirs 
of bacteria harbouring genes encoding resistance to carbapenems. Isolated carbapenemase-producing bacteria 
species were subjected to WGS to understand the genetic platforms linked to detected carbapenemase genes. The 
results provide further insight into the global epidemiology of this important group of antibiotic resistance genes.
Results
CRB were recovered from urban Nigerian wetlands. Various colonies of bacteria showing resist-
ance to meropenem were isolated on all agar types: Muller Hinton (MH), Eosine Methylene Blue (EMB), and 
Pseudomonas isolation (PI) agar used for bacteria isolation from all sediment samples analysed. A total of 65 
isolates showing different colony morphologies were isolated from Awba (AW = 14) and Apete (AP = 22) wet-
lands in Ibadan, and from Abule Agege (AA = 14) and Ogbe Creek (OC = 15) in Lagos (Fig. 1). According to their 
partial 16S rRNA gene sequences (about 1,300 bp) the strains belonged to six different genera (relative frequencies 
in parenthesis), namely Pseudomonas (52.3%), Stenotrophomonas (15.3%), Cupriavidus (12.3%), Burkholderia 
(9.2%), Pandoraea (6.2%) and Ralstonia (4.6%). Carbapenemase activity was detected by the Blue-Carba test in 
61 isolates (93.8%) with at least one representative of each genus among the carbapenemase-producing strains. 
The isolates negative in the Blue-Carba test belonged to the genera Cupriavidus (3 isolates from AP in Ibadan) 
and Ralstonia (1 isolate from OC). Members of the Enterobacteriaceae were not present among the cultured CRB 
as deduced by absence of lactose-fermenting colonies on EMB agar plates. However, other Enterobacteriaceae 
(E. coli, Enterobacter spp., Citrobacter spp.) with resistance to third generation cephalosporins, fluoroquinolones 
and sulphonamides were isolated from the same samples in an accompanying study (Adelowo et al., unpub-
lished), which suggests that there were indeed only few, if any, cultivable carbapenem-resistant Enterobacteriaceae 
at the sites.
blaVIM-5 was detected in isolates belonging to the Pseudomonas putida group. The metallo- 
beta-lactamase (MBL) gene blaVIM-5 was the only carbapenemase gene detected of all carbapenemase genes (blaVIM, 
blaKPC/BIC, blaNDM, blaIMP, blaSPM, blaAIM, blaDIM) screened for by PCR among the 61 carbapenemase-positive iso-
lates. This gene was found in nine isolates (prevalence rate of 15%) from AW and AP (2 samples each). The gene 
shared 99% nucleotide sequence identity with blaVIM-5 on the class 1 Integron of Enterobacter cloacae SMART 28 
(accession number LC169578). The search for the genetic basis of carbapenemase activity in the other 52 isolates 
is ongoing.
Figure 1. Location of sampling sites, indicated by filled squares (The map was created by Muhammad Arslan).
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In order to investigate the genetic background of the nine blaVIM-5-positive strains, their genomes were 
sequenced. Genome characteristics as well as isolation dates and origins of the isolates are provided in 
Supplementary Table S1. The strains were identified via complete 16S rRNA gene sequence comparison and 
Multi Locus Sequence Analysis (MLSA) of 520 single copy core gene products as Pseudomonas plecoglossicida and 
Pseudomonas guariconensis (Fig. 2); members of the P. putida group32,33. Strains identified as P. plecoglossicida 
clustered into two groups (MR69, MR70, MR134 and MR135 from AW, and MR83, MR170 from AP). Whole 
genome-wide SNP counts ranged from 19 to 55 for the most closely related strains, showing that the strains are 
not identical (Fig. S1).
blaVIM-5 was present on 3 different class 1 integrons structures in the isolates. Analysis of the 
genomes revealed the presence of blaVIM-5 on Tn402-like class 1 integrons with canonical 5′CS and 3′CS, 
defective transposition module, and three different gene cassette contents and arrangements (Fig. 3). All the 
blaVIM-5-bearing integrons contained the aminoglycoside adenyltransferase gene aadB sharing 100% sequence 
identity with aadB from P. aeruginosa (accession number JF412714)34 and the carbenicillin-hydrolysing class A 
beta-lactamase gene blaPSE-1 sharing 100% sequence identity with blaPSE-1 from P. aeruginosa RIVM-EMC2982 
(accession number CP016955). In P. plecoglossicida strains MR69, MR70, MR134 and MR135 the integron har-
boured the cassettes aadB|blaVIM-5|blaPSE-1. In P. plecoglossicida strains MR83 and MR170 the integron contained 
a second aadB copy in the order aadB|blaVIM-5|aadB|blaPSE-1. In P. guariconensis strains MR119, MR144, and 
MR149 the integron carried two identical copies of tnpA, encoding for a transposase of the IS116/IS110/IS902 
family with 99% sequence identity with transposase of P. aeruginosa (accession number EF614235)35, as well as 
smr2, encoding for a small multidrug resistance efflux protein sharing 75% sequence identity with smr2 from 
P. aeruginosa (accession number KC776907) in the order blaVIM-5|aadB|tnpA|blaPSE-1|smr2|tnpA. Based on 
sequence analysis of the integrase genes, the gene cassettes on the integrons were under the control of weak pro-
moters PcW and a second inactive promoter P2. Weak promoters usually have strong integrase excision activity36.
In P. plecoglossicida strains MR69, MR70, MR134 and MR135, the blaVIM-5-bearing integron was part of 491 
kb-large chromosomal contigs. At both integron ends, defined by canonical 25 bp-long inverted repeats IRi and 
IRt, there were identical copies of an IS6 family transposase IS6100 followed by a second IRt copy. At the 5′-CS 
side of the integron there was another integron which lacked blaVIM-5 but was otherwise 100% identical with the 
blaVIM-5-bearing one. At the Tn402-derivative side, the IS6-type transposase gene was adjacent to a 2.3 kb-long 
sequence with 100% nucleotide sequence identity to the adjacent region of class 1 integrons on the large plas-
mids pBM413 (from P. aeruginosa strain PA121617; accession number CP016215) and pSY153-MDR (from P. 
putida strain SY153, accession number KY883660). The 4 genes within these 2.3 kb region encode for hypothet-
ical proteins conserved in Pseudomonas and some other Gammaproteobacteria. Following those genes was a 
477 kb-large region wich had high synteny with a segment in the chromosome of P. putida KT2440 (accession 
number AE015451). For the other sequenced strains the genomic locus of the blaVIM-5 integrons could not be 
resolved and identical integrons without blaVIM-5 were not detected. However, none of the contigs appeared to be 
derived from plasmids. All sequenced strains also carried a Tn402-like class 1 integron with bcr2, encoding for 
bicyclomycin resistance protein as sole gene cassette.
Resistance phenotypes and additional resistance genes identified via WGS. In addition to their 
various phylogenetic affiliations with the P. putida group, the reaction of the nine isolates to antibiotics used in 
determination of minimum inhibitory concentration (MIC) differed (Table 1). All isolates showed resistance 
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Figure 2. Phylogenetic tree of blaVIM-5-carrying isolates from Nigerian wetlands and selected members of 
Pseudomonas putida group isolated from fish in Asia (DSM 15088, NZBD9, XDHY-P, NB2011 andDJ-1), soil/
sediment in USA (KCJK7865), China (NyZ12) and India (TND35). The tree is based on MLSA of 520 single 
copy core gene products. Bootstrap support was >90% at all nodes (1000 permutations). Sequence distance is 
indicated by the horizontal bar.
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to the highest concentration of imipenem (IMP) and sulphamethoxazole (SMX), and the six P. plecoglossicida 
isolates were resistant to ciprofloxacin (CIP). The MICs of aztreonam (ATM) for MR70 and MR134 as well as 
the MICs of ceftazidime (CAZ) for MR83, MR170, MR119 and MR149 were different for each isolate, further 
confirming that the strains were not identical.
Figure 3. Features of class 1 integrons carrying the carbapenemase gene blaVIM-5 in members of the 
Pseudomonas putida group isolated from Nigerian wetlands. The range of the canonical 5′-CS, 3′-CS, and 
defective Tn402 derivative are indicated by brackets in the depiction for strains MR69, MR70, MR134, and 
MR135. The integrons were bordered by 25 bp-long canonical inverted repeats IRi and IRt, indicated by 
filled triangles. Besides one non-synonymous SNP at nt position 66 of intl1, the integron backbones were 
100% identical. The attl1 site at which the antibiotic resistance gene cassettes were inserted is indicated with a 
diamond.
Strain
MIC (mg/L)a Additional Genes Detected 
by WGS AnalysisIMP ATM CAZ CIP SMX
Pseudomonas plecoglossicida MR69 >32 48 >256 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. plecoglossicida MR70 >32 128 >256 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. plecoglossicida MR134 >32 64 >256 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. plecoglossicida MR135 >32 48 128 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. plecoglossicida MR83 >32 16 96 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. plecoglossicida MR170 >32 16 >256 >32 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetC, gyrA mutation
P. guariconensis MR119 >32 24 32 0.25 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetB, tetC, tetG, floR
P. guariconensis MR144 >32 32 32 0.25 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetB, tetC, tetG, floR
P. guariconensis MR149 >32 16 >256 0.38 >1024 aph(3″)-lb, aph(6″)-id, ampC, macAB, tetB, tetC, tetG, floR
Table 1. Antibiotic resistance phenotype and resistance genes profile of the 9 blaVIM-5-producing isolates 
from the Nigerian wetlands. aAntimicrobials abbreviations and test concentrations. IMP: Imipenem; ATM: 
Aztreonam; CAZ: Ceftazidime; CIP: Ciprofloxacin; SMX: Sulfamethoxazole; 0.002–32 mg/L (IMP and CIP), 
0.016–256 mg/L (ATM and CAZ), 0.064–1024 mg/L (SMX).
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Ten additional antibiotic resistance genes were identified in the genomes of the strains conferring resistance to 
six classes of antibiotics (Table 1). The aph(3′)-ib, aph(6′)-Id, macAB, tetC and ampC were common to all strains 
while the tetB, tetG,and floR were detected exclusively in P. guariconensis MR119, MR144 and MR149. A gyrA 
mutation (Thr83Ile) conferring fluoroquinolone resistance was present in all the P. plecoglossicida strains but not 
in the P. guariconensis isolates, consistent with the sensitivity of the latter strains to ciprofloxacin.
Discussion
This study reports the occurrence and genetic environment of blaVIM-5 in bacteria isolated from four Nigerian 
wetlands. Ultimately, this is no suprise given the widespread pollution of aquatic ecosystems in Nigeria. The 
detection of the blaVIM-5 gene in closely related members of the P. putida group suggests an establishment of these 
species as reservoir of blaVIM in the two wetland ecosystems. Members of the P. putida group are typically found 
in the environment but have also been reported as important opportunistic pathogens37 and reservoir-hosts of 
metallo-beta-lactamases38.
Previously, reports of blaVIM-5 have only been limited to clinical bacterial isolates from the Asian and African 
continents being identified in clinical isolates of P. aeruginosa, K. pneumoniae, Serratia marcescens, Enterobacter 
cloacae and Proteus mirabilis from Turkey27,39–41, Thailand27, Nigeria27, India42 and China (unpublished, GenBank 
Accession Number KM589496). This however, is the first report of blaVIM-5 in environmental bacterial isolates. 
There is no information available on the gene context of the blaVIM-5 detected in the Nigerian clinical isolates. 
However, much like we observed in this study, the blaVIM-5 in the clinical isolates reported in some of the afore-
mentioned studies39,41,42 and the unpublished Chinese isolate are located on class 1 integrons. Interestingly, in all 
the clinical isolates, the blaVIM-5 occurred as the first cassette on the integrons, while in six of our environmental 
isolates (MR69, MR70, MR83, MR134, MR135 and MR170), the gene occurred as the second cassette suggest-
ing different evolutionary pathways for the blaVIM-5–bearing class 1 integron in the clinical and environmental 
isolates.
The localisation of blaVIM-5 within three novel integron structures in two species of Pseudomonas recovered 
from two wetlands points to a high propensity for mobilisation of this gene to other hosts within and outside 
the wetland ecosystem. This propensity is underscored by the involvement of weak promoters PcW and inactive 
second promoters P2 in the control of this gene and the associated gene cassettes in all isolates. A previous study 
has reported an inverse correlation between promoter strength and excision activity36. Similar to this observation, 
the blaVIM-5 on the class 1 integron of E. cloacae SMART 28, a clinical isolate from Turkey is also under the control 
of a weak promoter PcW41. Further, the genome sequences of MR69, MR70, MR134 and MR135 revealed the 
presence of an additional integron which is otherwise 100% identical to the blaVIM-5–bearing integron except for 
the absence of blaVIM-5, suggesting that the acquisition of the blaVIM-5 cassette was a recent event. It also appears 
that the capturing of the blaVIM-5 cassette by the integrons of all sequenced strains occurred via three independent 
events judging from the localisation of the cassette in three novel integron structures.
Reports of carbapenemase genes in bacteria from environmental sources in Nigeria are not available for a 
comparative assessment of our results. However, the frequency of carbapenemase genes detection in this study is 
slightly higher than the prevalence rates of 5.5% and 10.2% reported in two of the hospital-based studies carried 
out in Nigeria22,23. Further, while we detected only blaVIM, these two Nigerian studies detected other carbapene-
mase genes in addition to blaVIM and the carriage of multiple carbapenemase genes among the investigated CRB. 
The three independent Nigerian studies are however similar in one respect: the low detection frequency of known 
carbapenemase genes among the CRB tested. This might be an indication of the presence of novel gene(s) or gene 
variants in these strains, or the mediation of carbapenem resistance by intrinsic carbapenemase genes43–45.
To conclude, we isolated bacteria carrying the MBL gene blaVIM-5 in members of the P. putida group in two 
polluted wetlands in southwestern Nigeria. The link between the study sites and the city’s water supply system 
heightens the public health risk associated with this observation as this, together with the association of the 
gene with seemingly active mobile genetic elements, increases the chance of dissemination of the gene to the 
human population through the water-human route. There is therefore an urgent need for further studies aimed at 
assessing the actual distribution and persistence of CRB and corresponding carbapenemase genes in the Nigerian 
aquatic ecosystems.
Materials and Methods
Sampling sites and sample collection. Four wetlands in Ibadan and Lagos, located in south-western 
Nigeria (Fig. 1), were selected as sampling sites. In Ibadan, Awba (AW) wetland (07.4468°N, 03.8763°E) is within 
a university campus and receives untreated wastewater and sewage from at least five of the university’s hostel facil-
ities, the university’s fish farm and the zoological garden. Apete (AP) wetland (07.4577°N, 03.8828°E) is located 
behind the campus of a polytechnic and receives domestic wastewater from a network of sources including hostel 
facilities of the polytechnic and seepages from a solid waste dump site. Water from AW drains into Awba Dam, 
which serves as the university’s water reservoir. Awba Dam and AP drain into Eleyele Lake, which is the water 
source for about half of Ibadan’s population of 3.5 million residents. In Lagos, Abule Agege (AA) (06.5145°N, 
03.4002°E) is a large expanse of mangrove wetland located within a university campus. The wetland has a direct 
link to the Lagos Lagoon and is polluted from several non-point sources including untreated sewage and waste-
water from a network of hostel facilities of the university and direct discharge of wastewater from freshwater 
aquaculture. Ogbe Creek (OC) (06.5135°N, 03.3937°E) runs through a mangrove swamp within the campus 
of the same university as AA. Its primary source of pollution is seepages from a solid waste dump site located 
upland about 300 meters from the creek. Triplicate sediment samples were collected monthly from October 2014 
through January 2015 from the upper 1 cm portion of each wetland. The samples were pooled together and stored 
at −80 °C until processed for isolation of bacteria.
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Bacteria isolation. CRB were isolated from the sediment samples by selective enrichment on MH agar, 
EMB agar, and PI agar, all supplemented with 4 mg/L meropenem (Glentham Life Sciences, Corsham, UK) as 
described12, except that saline suspensions (25 g sediment in 225 mL 0.85% saline) of pooled triplicate samples 
were inoculated into tryptone soy broth (TSB) supplemented with meropenem (4 mg/L) and the enriched TSB 
cultures (200 µl each) were plated on selective EMB, PI and MH agar plates. Further, all incubations took place at 
35 °C. All carbapenem-resistant isolates representing different colony morphotypes based on size, colour, surface 
texture and colony edge were selected from the plates, subcultured on selective MH plates and stored in 15% 
(w/v) glycerol at −80 °C.
Identification of carbapenem-resistant bacteria. Total genomic DNA was extracted (DNeasy blood 
and Tissue Kit, Qiagen) and used as template in PCR with universal primers 27F46 and 1378R47 targeting the 
bacterial 16 S rRNA gene. Amplicons were purified (GeneJet PCR Purification Kit, Thermo Fisher Scientific), 
sequenced from both ends (Macrogen Europe, Amsterdam) and obtained sequences were used in BLASTn 
searches (https://blast.ncbi.nlm.nih.gov/Blast) for phylogenetic assignment of the isolates.
Phenotypic detection of carbapenemase production, and PCR survey of carbapenemase and 
other beta-lactamase genes. Phenotypic detection of carbapenemase activity was carried out by the 
Blue-Carba Test48. Surveys for carbapenemase genes (blaVIM, blaKPC/BIC, blaNDM, blaIMP, blaSPM, blaAIM, blaDIM) 
were carried out via multiplex PCR with primers and conditions previously described49 using Kappa 2G Fast 
Multiplex PCR Mix (KAPA Biosystems, Boston Massachusetts, USA). Multiplex PCR was also used to search 
for other beta-lactamases (blaTEM, blaSHV, blaCTX-M, blaVEB, blaGES, blaPER, blaOXA-1, blaOXA-2, blaOXA-10, blaOXA-23, 
blaOXA-24, blaOXA-48, blaOXA-51, blaOXA-58, blaCMY-1, blaCMY-2, blaACC, blaACT, blaDHA and blaFOX) with primers and 
conditions previously described49,50. Pseudomonas aeruginosa 11 (blaVIM-2), P. aeruginosa 4 (blaIMP-15), Klebsiella 
pneumoniae ST512 (blaKPC-13), K. pneumoniae Mnasey (blaTEM-1, blaSHV-11, blaCTX-M-15, blaNDM-1), Acinetobacter 
baumannii AYE (blaVEB), and Providencia rettgeri H1736 (blaNDM-1) were used as positive controls. The correct 
amplification of any detected gene was confirmed with single primer pairs using DreamTaq Green Master mix 
(Thermo Fisher Scientific) as reported previously51. Amplicons were purified and sequenced from both ends with 
respective primers used in PCR (GATC, Konstanz, Germany).
MIC determination. The MICs of imipenem (IMP), aztreonam (ATM), ceftazidime (CAZ), ciprofloxacin 
(CIP) and sulfamethoxazole (SMX) were determined by E-test (Liofilchem Diagnostici, Italy) on MH agar plates 
according to the manufacturer’s instructions. MH agar plates were inoculated with standardised (0.5 McFarland 
Standard) saline suspension of each isolate prepared from overnight cultures on MH agar plates. E-Test strips 
were carefully layered on each inoculated plate and plates were incubated at 35 °C for 18 hrs. Results were inter-
preted with the CLSI MIC interpretive criteria for P. aeruginosa52.
WGS and analyses of blaVIM containing isolates. Between 500–1000 ng genomic DNA of each isolate 
was sheared with a Covaris S220 sonication device (Covaris Inc.; Massachusetts, USA) with the following settings: 
55 s, 175 W, 5% Duty factor, 200 cycles of burst, 55.5 μL input volume. Sequencing libraries were prepared by using 
the NEBNext® Ultra™ DNA Library Prep Kit for Illumina® (New England Biolabs, Frankfurt, Germany) as per 
the manufacturer’s instructions. The libraries were sequenced with an Illumina® MiSeq machine using v3 chem-
istry and paired-end approaches with 76 cycles (strains MR69, MR70, MR83, MR119, MR144, MR170) and/or 
301 cycles (strains MR69, MR83, MR119, MR134, MR135, MR149) per read. Raw sequences were subjected to 
adapter clipping and quality trimming using Trimmomatic53, and processed reads were assembled with SPAdes 
v3.6.254. Assembly quality and taxonomic placement of the genome were assessed with CheckM v1.0.455. Prokka 
v1.11 was used for automated annotations56. Antibiotic resistance gene markers were searched for manually and 
via the Comprehensive Antibiotic Resistance Database (CARD)57. In strains MR69, MR70, MR134 and MR135 
the entire blaVIM-carrying integron as well as the linkages with the large chromosomal segment and the adjacent 
integron without blaVIM were Sanger sequenced. In the other strains PCR-mapping and Sanger sequencing were 
used for scaffolding of the gene cassettes.
Orthologs shared by the different isolates as well as selected references were determined using the bidirec-
tional BLAST+ approach implemented in Proteinortho 558. In order to determine the phylogenetic relationships 
between the isolates and references via Multi Locus Sequence Analysis (MLSA) with maximum resolution, the 
single copy core genome of all comparison genomes was determined, excluding all genes with duplicates or miss-
ing orthologs in any comparison genome. After alignment with MUSCLE59, the gene products were concatenated 
and un-alignable regions were filtered out using gblocks60. The remaining aligned conserved core genome prod-
uct amino acid residues (187,324 positions) were subjected to phylogenetic clustering using the Neighbor Joining 
algorithm with 1000 bootstrap permutations. Whole genome SNP analysis was carried out in CLC Genomics 
Workbench 11.0.1.
Data Availability Statement
The 16S rRNA gene sequences of the isolated CRB are available in DDBJ/ENA/GenBank under accession num-
bers MG674312-MG674376. The WGS projects have been deposited at DDBJ/ENA/GenBank under the accession 
numbers PJCJ00000000 - PJCR00000000.
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